News and Announcements
BioProspect Agrees to Royalties for Qcide IP Rights
- Published January 19, 2012 2:07PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
BioProspect Ltd has a new agreement with Bio-Gene Technology Ltd governing the intellectual property (IP) rights for natural insecticide Qcide, which is being developed as an environmentally friendly treatment for household and human pests.
BioProspect and the University of Western Sydney have assigned Qcide’s IP rights to Bio-Gene, in exchange for fees and royalties split between BioProspect and UWS.
——
To view the full article, please click the link below.